Rare disease drug varieties approved
RecordSTO-NAEE4RMBKC-EWWVM3ZC0P-1MS13R
China · 2024
Rare disease drug varieties approved in China was 39 in 2024 (State Council).
New drug approvals in China: every year, the rank and how it is measured
- Publisher
- State Council
- Authority tier
- T1 Official
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
不只注射用利纳西普，据罕见病信息网统计，全年批准罕见病用药39个品种，覆盖了34种罕见病。
Checked: the figure 39is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
State Council of China. (2024). 全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网. Retrieved September 17, 2026, from https://www.gov.cn/zhengce/202501/content_6997982.htm. Via StatOrigin, https://statorigin.org/stat/stat_NAEE4RMBKCEWWVM3ZC0P1MS13R
Other formats: MLA, Chicago, BibTeX
- MLA
- State Council of China. "全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网." 2024, https://www.gov.cn/zhengce/202501/content_6997982.htm. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_NAEE4RMBKCEWWVM3ZC0P1MS13R.
- Chicago
- State Council of China. "全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网." 2024. https://www.gov.cn/zhengce/202501/content_6997982.htm. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_NAEE4RMBKCEWWVM3ZC0P1MS13R.
- BibTeX
- @misc{statecouncil2024rare1ms13r, author = {{State Council of China}}, title = {全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市\_政策解读\_中国政府网}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_NAEE4RMBKCEWWVM3ZC0P1MS13R}, note = {Original source: https://www.gov.cn/zhengce/202501/content\_6997982.htm. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- State Council of China · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- 全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网
- Type
- Press release
- Published
- —
- Locator
- 更好满足临床急需
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_NAEE4RMBKCEWWVM3ZC0P1MS13R